This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07993/identifier/chemspider/
n7http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n8http://linked.opendata.cz/resource/drugbank/drug/DB07993/identifier/pdb/
n4http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://linked.opendata.cz/resource/drugbank/drug/DB07993/identifier/pubchem-compound/
n9http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n14http://linked.opendata.cz/resource/drugbank/drug/DB07993/identifier/pubchem-substance/
n10http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n6http://linked.opendata.cz/resource/drugbank/drug/DB07993/identifier/drugbank/

Statements

Subject Item
n2:DB07993
rdf:type
n9:Drug
n9:group
experimental
owl:sameAs
n4:DB07993 n7:DB07993
dcterms:title
N~3~-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE
adms:identifier
n6:DB07993 n8:IP6 n12:9682717 n13:11507920 n14:99444464
n9:IUPAC-Name
n10:271B5393-363D-11E5-9242-09173F13E4C5
n9:InChI
n10:271B5399-363D-11E5-9242-09173F13E4C5
n9:Molecular-Formula
n10:271B5398-363D-11E5-9242-09173F13E4C5
n9:Molecular-Weight
n10:271B5395-363D-11E5-9242-09173F13E4C5
n9:Monoisotopic-Weight
n10:271B5396-363D-11E5-9242-09173F13E4C5
n9:SMILES
n10:271B5397-363D-11E5-9242-09173F13E4C5
n9:Water-Solubility
n10:271B5391-363D-11E5-9242-09173F13E4C5
n9:logP
n10:271B5392-363D-11E5-9242-09173F13E4C5 n10:271B538F-363D-11E5-9242-09173F13E4C5
n9:logS
n10:271B5390-363D-11E5-9242-09173F13E4C5
n9:H-Bond-Acceptor-Count
n10:271B539F-363D-11E5-9242-09173F13E4C5
n9:H-Bond-Donor-Count
n10:271B53A0-363D-11E5-9242-09173F13E4C5
n9:InChIKey
n10:271B539A-363D-11E5-9242-09173F13E4C5
n9:Polar-Surface-Area--PSA-
n10:271B539B-363D-11E5-9242-09173F13E4C5
n9:Polarizability
n10:271B539D-363D-11E5-9242-09173F13E4C5
n9:Refractivity
n10:271B539C-363D-11E5-9242-09173F13E4C5
n9:Rotatable-Bond-Count
n10:271B539E-363D-11E5-9242-09173F13E4C5
n9:Bioavailability
n10:271B53A5-363D-11E5-9242-09173F13E4C5
n9:Ghose-Filter
n10:271B53A7-363D-11E5-9242-09173F13E4C5
n9:MDDR-Like-Rule
n10:271B53A8-363D-11E5-9242-09173F13E4C5
n9:Number-of-Rings
n10:271B53A4-363D-11E5-9242-09173F13E4C5
n9:Physiological-Charge
n10:271B53A3-363D-11E5-9242-09173F13E4C5
n9:Rule-of-Five
n10:271B53A6-363D-11E5-9242-09173F13E4C5
n9:Traditional-IUPAC-Name
n10:271B5394-363D-11E5-9242-09173F13E4C5
n9:pKa--strongest-acidic-
n10:271B53A1-363D-11E5-9242-09173F13E4C5
n9:pKa--strongest-basic-
n10:271B53A2-363D-11E5-9242-09173F13E4C5